Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CT3001 |
Synonyms | |
Therapy Description |
Limited information is currently available on CT3001, a putative GPR35 inhibitor (Oct 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CT3001 | CT-3001|CT 3001 | Limited information is currently available on CT3001, a putative GPR35 inhibitor (Oct 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06598007 | Phase Ib/II | CT3001 | A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors | Recruiting | USA | 0 |